申请人:Boehringer Ingelheim Pharma KG
公开号:US06200976B1
公开(公告)日:2001-03-13
Quinoxazolines having antithrombotic activity. Exemplary of those disclosed are:
4-{[6-(N-carboxymethyl-quinolin-8-yl-sulphonylamino)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl]-methyl}-benzamidine,
4-{[6-(1-(N-cyclopentyl-carboxymethylcarbonylamino)-cyclo-propyl)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl]-methyl}-benzamidine, and
4-{[7-(N-carboxymethylaminocarbonyl-ethylamino)-4-methyl-quinolin-2-yl]-oxo}-benzamidine.
奎诺沙唑啉具有抗血栓活性。其中一些示例包括:4-〔6-(N-羧甲基喹啉-8-基磺胺基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基〕-甲基-苯甲酰胺,4-〔6-(1-(N-环戊基-羧甲基羰基氨基)-环丙基)-1-甲基-2-氧代-1,2-二氢喹啉-3-基〕-甲基-苯甲酰胺,以及4-〔7-(N-羧甲基氨基甲酰基乙基氨基)-4-甲基喹啉-2-基〕-氧代-苯甲酰胺。